1. Tsao C, Aday A, Almarzooq Z, et al. Heart Disease and Stroke Statistics-2023 Update: a report from the American Heart Association. Circulation 2023; 147: e93-621.
2.
Lindstrom M, DeCleene N, Dorsey H, et al. Global burden of cardiovascular diseases and risks collaboration, 1990-2021. J Am Coll Cardiol 2022; 80: 2372-425.
3.
Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407-77.
4.
Jonik S, Marchel M, Pedzich-Placha E, et al. Optimal management of patients with severe coronary artery disease following Multidisciplinary Heart Team approach – insights from Tertiary Cardiovascular Care Center. Int J Environ Res Public Health 2022; 19: 3933.
5.
Balducci L, Ershler W, Krantz S. Anemia in the elderly-clinical findings and impact on health. Crit Rev Oncol Hematol 2006; 58: 156-65.
6.
Sabatine M, Morrow D, Giugliano R, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111: 2042-9.
7.
Nikolsky E, Mehran R, Aymong E, et al. Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 2004; 94: 1023-7.
8.
Dégano I, Elosua R, Marrugat J. Epidemiology of acute coronary syndromes in Spain: estimation of the number of cases and trends from 2005 to 2049. Rev Esp Cardiol (Engl Ed) 2013; 66: 472-81.
9.
Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968; 405: 5-37.
10.
Kwok C, Tiong D, Pradhan A, et al. Meta-analysis of the prognostic impact of anemia in patients undergoing percutaneous coronary intervention. Am J Cardiol 2016; 118: 610-20.
11.
Rathod K, Jones D, Rathod V, et al. Prognostic impact of anaemia on patients with ST-elevation myocardial infarction treated by primary PCI. Coron Artery Dis 2014; 25: 52-9.
12.
Lee P, Kini A, Ahsan C, et al. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 2004; 44: 541-6.
13.
Nikolsky E, Aymong E, Halkin A, et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 2004; 44: 547-53.
14.
Bertrand O, Larose E, Rodés-Cabau J, et al. Incidence, range, and clinical effect of hemoglobin changes within 24 hours after transradial coronary stenting. Am J Cardiol 2010; 106: 155-61.
15.
Hosseini S, Ansari M, Lotfi Tokaldany M, et al. Association between preprocedural hemoglobin level and 1-year outcome of elective percutaneous coronary intervention. J Cardiovasc Med (Hagerstown) 2014; 15: 331-5.
16.
Jiang L, Gao Z, Song Y, et al. Impact of anemia on percutaneous coronary intervention in Chinese patients: a large single center data. J Interv Cardiol 2018; 31: 826-33.
17.
Lorente V, Aboal J, Garcia C, et al. Anemia in patients with high-risk acute coronary syndromes admitted to Intensive Cardiac Care Units. J Geriatr Cardiol 2020; 17: 35-42.
18.
Oleksiak A, Kępka C, Rucińska K, et al. Hemoglobin level as a predictor of major adverse cardiac events during a long-term follow-up in patients with coronary artery disease. Pol Arch Intern Med 2022; 132: 16377.
19.
Anker S, Voors A, Okonko D, et al. Prevalence, incidence, and prognostic value of anaemia in patients after an acute myocardial infarction: data from the OPTIMAAL trial. Eur Heart J 2009; 30: 1331-9.
20.
Cavusoglu E, Chopra V, Gupta A, et al. Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome. Am J Cardiol 2006; 98: 580-4.
21.
McKechnie S, Smith D, Montoye C, et al. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 2004; 110: 271-7.
22.
Mann J. What are the short-term and long-term consequences of anaemia in CRF patients? Nephrol Dial Transplant 1999; 14: 29-36.
23.
Pereira A, Sarnak M. Anemia as a risk factor for cardiovascular disease. Kidney Int Suppl 2003; 87: 32-9.
24.
Duke M, Abelmann W. The hemodynamic response to chronic anemia. Circulation 1969; 39: 503-15.
25.
Horina J, Schwaberger G, Brussee H, et al. Increased red cell 2,3-diphosphoglycerate levels in haemodialysis patients treated with erythropoietin. Nephrol Dial Transplant 1993; 8: 1219-22.
26.
Lanser L, Fuchs D, Scharnagl H, et al. Anemia of chronic disease in patients with cardiovascular disease. Front Cardiovasc Med 2021; 8: 666638.